Virtual event: Pharma conclave series 2024
May 16 | September 17 | October 23-24
10:00 a.m.–12:00 p.m. CET
SCIEX offers the platform for the experts to take the stage and drive technological progress
Welcome to Pharma conclave series 2024 – where our customers’ expertise meets innovation, transforming your knowledge and empowering you to revolutionize your work processes. Join us in discovering techniques that will enhance your skills to accelerate your daily operations in the development of new drugs.
Event 1: Pharma omics | This event is now over
Event 1: Pharma omics | This event is now over
May 16, 10:00 a.m. – 12:00 p.m.
Lost in translation? Translational research meets drug discovery and development – 3rd edition
Topics covered:
‘Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics’ by Bruno Manadas, at CNC
‘Scalable and automated workflows for global plasma proteomics by standardized LC-MS’ by Dorte Bekker-Jensen, at Evosep
‘Quantitative, standardized and reproducible metabolomics solutions in pharmaceutical R&D’, by Stefan Ledinger and Markus Langsdorf, at Biocrates Life sciences
Multi-omics analysis on mouse plasma in a pre clinical development of a drug in Alzheimer
Event 2: Impurities | This event is now over
Event 3: Pharma
October 23-24, 10:00 a.m.- 12:00 p. m. CET | 1:30 p.m. - 3:30 p. m. IST
The pharma connection
From discovery to QA/QC. All the process to bring a new treatment to the patients is following a path to connect the different stages until the magic happens.
Join to see how the scientists are generating the needed tricks to connect the initial though with the final formulation.
Day 1
| Time | Title | Speaker |
|---|---|---|
| 10:00 - 10:30 | Metabolomics screening kits for use in clinical trials | Heike Wiese, Nuvisan |
| 10:30 – 11:00 | Sphingolipid biomarkers in neurodegenerative drug development | Jose Carlos Gonzalez, AMSbiopharma |
| 11:00 – 11:30 | Parallel setup of a series of micro LC methods, coupled with the low-resolution mass spec (API7500) for TG2 inhibitors | Davide Massari and Chiara Olmi, ERBC Group |
| 11:30 – 12:00 | PFAS analysis and mass spectrometry: Beyond environmental, food and packaging. What about cosmetic and pharmaceutical products? | Emiliano De Dominicis, Merieux |
Day 2
| Time | Title | Speaker |
|---|---|---|
| 10:00 - 10:30 | Metabolomics: From target engagement to metabolic phenotyping. Applications in drug discovery | Filippos Michopoulos, Astrazeneca |
| 10:30 - 11:00 | Development of an LC-MS Method to Quantify Endogenous Urea in Mouse Plasma and BAL. | Benjamin Smith, Cyprotex |
| 11:00 - 11:30 | Optimization of extraction & LC-MS conditions for the bioanalysis of antibody drug conjugates with diverse chemistries | John Perkins, KCAS |
| 11:30 - 12:00 | Preparation of rodent whole blood and plasma microsamples for LC-MS/MS bioanalysis in toxicology studies | Birgitte Støvring, Scantox |
Speakers:
Dr. Heike Wiese, Head of New Modalities LC/MS Bioanalyis, Nuvisan
Dr. Heike Wiese is a Chemist by training with a long-standing experience in biochemistry, microbiology and biological mass spectrometry. She started academic research in the field of proteomics at the Ruhr-University in Bochum. She continued working in the field of proteomics during PostDoc and Scientist positions at the University of Freiburg and at Ulm University. During these positions she was fascinated by finding solutions for bioanalytical problems in a multitude of biological systems. She joined Nuvisan Neu-Ulm in June 2020 as Senior Scientist in LC/MS Method Development and Validation. Since April 2022, she is heading the New Modalities LC/MS team.
Birgitte Støvring, MSc, PhD., Scantox
Birgitte joined Scantox in 2022 as the head of analysis and preparation in Ejby Denmark. Prior to this she has several years of experience as a Bioanalytical Director and Bioanalytical Scientist in the CRO and pharmaceutical industry.
Ben Smith, Scientist Discovery Bioanalytical, Cyprotex UK
Studied Chemistry at the University of Bath and graduated in 2016. Since then Ben has been working in analytical chemistry for almost 8 years, most of which has been in bioanalysis. Ben has been at Cyprotex for almost 4 years in the bioanalytical team supporting early stage drug discovery projects.
Emiliano de Dominicis, Chemistry Research Director, Mérieux NutriSciences
Emiliano De Dominicis is a researcher with over twenty years of experience in food and pharmaceutical safety, following both private and academic sectors, and he is now Director of Chemical Research - Project Manager at Mérieux NutriSciences. With a Research and Development in Analytical Chemistry dedicated team, Emiliano is responsible for Mérieux NutriSciences Global Research Projects and Scientific Center. Moreover, Emiliano De Dominicis actively participates in funded scientific projects (regional, national and European), scientific congresses as speaker, and writes articles published in specialized scientific journals. and AMS as Project Manager and Principal Scientist.